Navigation Links
New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds

COX-1 and COX-2 enzymes may be blocked by pain medications such as Advil and Vioxx in a more complex manner than was previously understood, a Queen's University study has found.

"The results of the study have potential implications for how we classify the commonly used anti-inflammatory and pain drugs for aches, pains, and fever," says Colin Funk, a professor of Biochemistry and Physiology at Queen's and Canada Research Chair in Molecular, Cellular and Physiologiocal Medicine.

Published on-line in Nature Medicine, the study was conducted in collaboration with University of Pennsylvania researchers.

The study was initiated to explore the biochemistry associated with COX-2 inhibitors such as Vioxx, Bextra and Celebrex, which are now associated with an increased incidence of heart attack and stroke. Researchers looked at mice that were genetically modified so that their COX-2 was inhibited ?to create a physiology in mice that roughly mimics that of users of COX-2 inhibitors. They found that the COX-1 enzymes in the mice "hooked up" in an unanticipated way with their remaining COX-2 enzymes creating what is called a new heterodimer.

Dr. Funk's co-researcher, Queen's biochemist Robert Campbell, has developed a computer model to show how the COX-1/COX-2 molecules can associate.

"It's possible the COX-2 inhibitor medications may affect the resulting new enzyme which is a mix of COX-1 and COX-2," says Dr. Funk.

This effect is being further explored by scientists and may lead to a broadened understanding of the biochemistry of common pain medications. It is now pointing toward possible alternatives to drugs like Vioxx and Celebrex, says Dr. Funk.

A study published April 13 by The Journal of Clinical Investigation (JCI) by the same research team found that new types of anti-inflammatory drugs may reduce COX-2 cardiovascular problems. That study was conducted after this one and incorporated the genetically modified mice created in this study.

The JCI study found a drug target that might substitute for COX-2: an enzyme called microsomal prostaglandin E synthase (mPGES)-1. The researchers showed that this drug did not predispose the animals to thrombosis or elevate blood pressure.


'"/>

Source:Queen's University


Related biology news :

1. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
2. Zebrafish may hold key to understanding human nerve cell development
3. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
4. Researchers make gains in understanding antibiotic resistance
5. Brain-mapping technique aids understanding of sleep, wakefulness
6. New understanding of DNA repair may pave way to cancer treatments
7. NYU and MSKCC research provides model for understanding chemically induced cancer initiation
8. Virologists make major step towards understanding the process of HIV infection
9. New understanding of cell movement may yield ways to brake cancers spread
10. Proteomics brings researchers closer to understanding microbes that produce acid mine drainage
11. New understanding of jet lag
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... POWAY, Calif. (PRWEB) , ... October 16, 2018 , ... ... taken to look for a possible tumor and instead, Sam’s veterinarian found that he ... not experiencing any obvious discomfort, so his owner placed him on supplements for the ...
(Date:10/16/2018)... ... October 15, 2018 , ... Modality Solutions, ... regulated industries, is a silver sponsor and exhibitor at the Executive Platforms’ Biomanufacturing ... The Biomanufacturing World Summit brings together the “who’s who” of pharmaceutical executives, cutting-edge ...
(Date:10/16/2018)... Utah and BOSTON (PRWEB) , ... ... ... CallTower , a global leader in delivering cloud-based enterprise-class unified communications and ... Boost delivers enhanced network stability by directly connecting CallTower data centers to ...
Breaking Biology News(10 mins):
(Date:10/5/2018)... Calif. (PRWEB) , ... October 04, 2018 , ... ... disease diagnostics with genomics, along with Duke University, announced today at IDWeek™ 2018 ... blood test that detects pathogen DNA in plasma, accurately identified causative pathogens in ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... solutions for biopharmaceutical R&D, today announced a new out-of-the-box integration of the ... a leading international pharmaceutical and laboratory equipment supplier. This enables the automatic ...
(Date:9/29/2018)... ... September 29, 2018 , ... ... and early-stage companies to access the power of influence analytics and data-driven engagement ... to a broader market that didn’t necessarily have access to the same financial ...
(Date:9/27/2018)... ... September 26, 2018 , ... Consumers ... of their primary care physicians, according to a new Zeldis Research and Schlesinger ... doctors were asked about consumer adoption of fitness and health wearables, remote monitoring, ...
Breaking Biology Technology: